2011
DOI: 10.1002/bjs.7640
|View full text |Cite
|
Sign up to set email alerts
|

Cost–utility of bariatric surgery for morbid obesity in Finland

Abstract: Surgery for morbid obesity increases health-related quality of life, and reduces the need for further treatments and total healthcare costs. According to this analysis, non-operative care would be more costly for the Finnish healthcare system on average after 5 years following surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
62
0
4

Year Published

2012
2012
2016
2016

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(67 citation statements)
references
References 71 publications
1
62
0
4
Order By: Relevance
“…The true economic costs of bariatric surgery are therefore likely to be higher than have so far been reported, as most analyses to date have failed to account for the need for subsequent surgery with a few exceptions [9,10]. The only economic evaluation that does address this issue assigned the same probability for reoperation after all procedures [11].…”
Section: Introductionmentioning
confidence: 91%
“…The true economic costs of bariatric surgery are therefore likely to be higher than have so far been reported, as most analyses to date have failed to account for the need for subsequent surgery with a few exceptions [9,10]. The only economic evaluation that does address this issue assigned the same probability for reoperation after all procedures [11].…”
Section: Introductionmentioning
confidence: 91%
“…Moreover, a growing literature associates bariatric surgery with reduced health care costs [47]. Postoperative outcomes, however, vary [8, 9].…”
Section: Introductionmentioning
confidence: 99%
“…Direct cost savings following BMS result from the reduced prevalence and severity of comorbid conditions which, in turn, translate into reduced comorbid condition medication costs, and reduced healthcare resource utilization. Surgical intervention has been associated with net cost savings compared with nonsurgical obesity care due to improved resolution of obesity-related comorbid conditions [47][48][49][50]. Significant reductions in both short-and long-term medication costs have also been shown [37,[51][52][53][54][55][56].…”
Section: Brief Overview Of Economic Evidence Of Bmsmentioning
confidence: 99%
“…Significant reductions in both short-and long-term medication costs have also been shown [37,[51][52][53][54][55][56]. Long-term, BMS has been shown to be less costly (1.5-fold lower) and more clinically effective than standard care over a 10-year span [47], and more costsaving over a 5-year period than standard medical management of diabetes (diet, exercise, and pharmaceutical therapy) [56].…”
Section: Brief Overview Of Economic Evidence Of Bmsmentioning
confidence: 99%